These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. Impact of a general practitioner educational intervention on osteoarthritis treatment in an elderly population. Rahme E; Choquette D; Beaulieu M; Bessette L; Joseph L; Toubouti Y; LeLorier J Am J Med; 2005 Nov; 118(11):1262-70. PubMed ID: 16271911 [TBL] [Abstract][Full Text] [Related]
30. Trends in cardiovascular drug utilization and drug expenditures in Canada between 1996 and 2001. Jackevicius CA; Tu K; Filate WA; Brien SE; Tu JV; Can J Cardiol; 2003 Nov; 19(12):1359-66. PubMed ID: 14631469 [TBL] [Abstract][Full Text] [Related]
31. Retrospective analysis of utilization patterns and cost implications of coxibs among seniors in Quebec, Canada: what is the potential impact of the withdrawal of rofecoxib? Rahme E; Hunsche E; Toubouti Y; Chabot I Arthritis Rheum; 2006 Feb; 55(1):27-34. PubMed ID: 16463408 [TBL] [Abstract][Full Text] [Related]
32. [Farmacoeconomical estimation of efficiency of different schemes of eradication therapy of Helicobacter pylori infection in children]. Kashnikova SN; Shcherbakov PL; Kashnikov VV; Tatarinov PA; Shcherbakova MIu Eksp Klin Gastroenterol; 2008; (7):111-8. PubMed ID: 19334454 [TBL] [Abstract][Full Text] [Related]
33. Impact of selective cyclooxygenase-2 inhibitors on anti-ulcer medication and non-steroidal anti-inflammatory drug use in patients with rheumatic disease. Joshua FF; Oakley SP; Major GA Intern Med J; 2004 Apr; 34(4):153-61. PubMed ID: 15086694 [TBL] [Abstract][Full Text] [Related]
34. [Drug committees in Denmark. Status and future challenges]. Rabøl R; Kampmann JP; Christensen HR Ugeskr Laeger; 2004 Aug; 166(35):2988-91. PubMed ID: 15387009 [No Abstract] [Full Text] [Related]
35. The cost-effectiveness and budget impact of intravenous versus oral proton pump inhibitors in peptic ulcer hemorrhage. Spiegel BM; Dulai GS; Lim BS; Mann N; Kanwal F; Gralnek IM Clin Gastroenterol Hepatol; 2006 Aug; 4(8):988-997. PubMed ID: 16844422 [TBL] [Abstract][Full Text] [Related]
36. Is more always better? Tuulonen A Acta Ophthalmol Scand; 2004 Aug; 82(4):377-9. PubMed ID: 15291927 [No Abstract] [Full Text] [Related]
37. Trends in opioid consumption in the Nordic countries 2002-2006. Hamunen K; Paakkari P; Kalso E Eur J Pain; 2009 Oct; 13(9):954-62. PubMed ID: 19091608 [TBL] [Abstract][Full Text] [Related]
39. Identifying drug usage patterns in the intensive care unit. Mann HJ; Wittbrodt ET Pharmacoeconomics; 1993 Oct; 4(4):235-9. PubMed ID: 10146912 [No Abstract] [Full Text] [Related]
40. 30-day mortality after peptic ulcer perforation among users of newer selective COX-2 inhibitors and traditional NSAIDs: a population-based study. Thomsen RW; Riis A; Munk EM; Nørgaard M; Christensen S; Sørensen HT Am J Gastroenterol; 2006 Dec; 101(12):2704-10. PubMed ID: 17026569 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]